p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
M C BrettG Poston

Abstract

Biomodulated 5-flourouracil (5-FU) chemotherapy may limit disease progression in up to 50% of patients with metastatic or unresectable carcinoma of the colorectum. However, treatment is expensive and may be toxic. Thus any predictors of response may be clinically and economically valuable. The p53 gene is mutated in more than 50% of colorectal tumours, usually resulting in p53 overexpression. It may regulate cell cycle progression and cellular response to DNA damage. The principal anticancer activity of 5-FU is due to its ability to induce DNA damage. Fifty-nine patients received bolus intravenous 5-FU/folinic acid over 3 months. Response was assessed by CAT scan (WHO criteria). p53 protein overexpression was determined immunohistochemically from paraffin sections of the original primary tumour and resected metastases. Tumour over expression of p53 protein was associated with a lower rate of response and a higher rate of deterioration both radiologically (P < 0.03) and clinically (P < 0.05, chi 2 test for trend), but did not predict survival from start of treatment. Response was unrelated to age, sex, tumour grade, site of disease or chemotherapy schedule. Tumour p53 protein overexpression alone cannot be used to select advance...Continue Reading

References

Aug 21, 1992·Cell·B Vogelstein, K W Kinzler
Sep 1, 1992·Cancer·S R Hamilton
Jul 2, 1992·Nature·D P Lane
Mar 15, 1989·Cancer·W A Bleyer
Jan 1, 1993·Virchows Archiv. A, Pathological Anatomy and Histopathology·X F SunB Nordenskjöld

❮ Previous
Next ❯

Citations

Sep 6, 2003·Surgical Oncology·Morton S KahlenbergNicholas J Petrelli
Apr 20, 2001·Critical Reviews in Oncology/hematology·V CatalanoS Cascinu
Mar 21, 2002·The Lancet Oncology·Julian W AdlardPhil Quirke
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Sep 5, 1998·Cancer Treatment Reviews·M T Seymour
Apr 24, 2002·Best Practice & Research. Clinical Gastroenterology·Boris PascheAl B Benson
Sep 29, 2000·International Journal of Cancer. Journal International Du Cancer·U ManneW E Grizzle
Jan 15, 1999·British Journal of Cancer·H L McLeod, G I Murray
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Wolfgang DietmaierFerdinand Hofstädter
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U KressnerG Lindmark
Aug 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H H BackusG J Peters
Jun 19, 1998·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N ScottJ B Elder
Mar 26, 2004·Gastroentérologie Clinique Et Biologique·Valérie BoigeMichel Ducreux
Dec 19, 2008·Gastroenterología y hepatología·Laura Sempere, Rodrigo Jover

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.